Respiratory phenotyping for new targeted approaches to treat sleep apnoea [ 2017 - ]

Research Grant

Researchers: Prof Danny Eckert (Principal investigator)

Brief description >9% of Australians have obstructive sleep apnoea (OSA). OSA has several causes. Untreated OSA is associated with major health consequences. <50% of OSA patients tolerate the main therapy, continuous positive airway pressure. New treatments are urgently required. This proposal aims to use & develop novel approaches to identify the causes of OSA on a per patient basis, improve current therapies & test if new targeted therapies can be used to treat OSA in appropriately selected patients.

Funding Amount $631,370.00

Funding Scheme Research Fellowships

Notes Research Fellowship